Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185679
Status:
TERMINATED
Last Update Posted:
2015-03-09
First Post:
2005-09-12
Brief Title:
Haploid Allogeneic Transplant Using the CliniMACS System
Sponsor:
Ginna Laport
Organization:
Stanford University
Study Overview
Official Title:
A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies
Status:
TERMINATED
Status Verified Date:
2015-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This study was superseded by the subsequent study IRB-15919 NCT01050764
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the proportion of patients with donor neutrophil engraftment within 30 days of allogeneic transplant To assess the incidence of acute GvHD during the first 100 days after transplantation
Detailed Description:
To assess the proportion of patients with donor neutrophil engraftment within 30 days of allogeneic transplant assess the incidence of acute GvHD during the first 100 days after transplantation and assess platelet engraftment graft failure chronic GvHD clinical safety and devise performance
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 77453 | OTHER | Historic IRB SQL database number | None |
| BMT123 | OTHER | None | None |
| NCI-2011-00424 | OTHER | None | None |